Most read article(s)

Article
Incidence and Impact of COVID-19 in MSA Survey From a Barcelona MS Unit
Maria Sepúlveda, Sara Llufriu, Eugenia Martínez-Hernández, et al.

January 27, 2021
Article
Clinical and Prognostic Value of Immunogenetic Characteristics in Anti-LGI1 Encephalitis
Sergio Muñiz-Castrillo, Julie Haesebaert, Laure Thomas, et al.

March 05, 2021
Article
Guillain-Barré syndrome: The first documented COVID-19–triggered autoimmune neurologic diseaseMore to come with myositis in the offing
Marinos C. Dalakas

June 09, 2020
Article
CNS Autoimmune Responses in BCMA-Deficient Mice Provide Insight for the Failure of Atacicept in MS
Gaurav Kumar, Zahra Maria, Uday Kohli, et al.

March 01, 2021
Clinical/Scientific Notes
Autoimmunity complicating SARS-CoV-2 infection in selective IgA-deficiency
Steffen Pfeuffer, Matthias Pawlowski, Gunther S. Joos, et al.

August 12, 2020
Article
COVID-19 and MS disease-modifying therapies
Joseph R. Berger, Rachel Brandstadter, Amit Bar-Or

May 15, 2020
Article
Biological Significance of Anti–SARS-CoV-2 AntibodiesLessons Learned From Progressive Multifocal Leukoencephalopathy
Navid Manouchehri, Lawrence Steinman, Olaf Stuve

December 24, 2020
Views & Reviews
Neuroprotective Properties of 4-Aminopyridine
Michael Dietrich, Hans-Peter Hartung, Philipp Albrecht

March 02, 2021
Article
No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribine
Julia Pakpoor, Giulio Disanto, Daniel R. Altmann, et al.

October 01, 2015
Article
Altered CSF Albumin Quotient Links Peripheral Inflammation and Brain Damage in MS
Marco Puthenparampil, Paula Tomas-Ojer, Thorsten Hornemann, et al.

March 01, 2021

Pages